Privigen

intravenous immunoglobulin (IVIG) · CSL Behring

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Privigen, covering 2013-04-04 to 2026-06-24. Get the full timeline:

Most recent: EMA Authorised: Privigen (human normal immunoglobulin (IVIg)) — CSL Behring GmbH